Page last updated: 2024-10-23

benzbromarone and Melanoma

benzbromarone has been researched along with Melanoma in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research Excerpts

ExcerptRelevanceReference
"Human malignant melanoma is characterised by unresponsiveness to conventional chemotherapy."1.30Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. ( Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, W1
Hauptmann, E1
Elbling, L1
Vetterlein, M1
Kokoschka, EM1
Micksche, M1

Other Studies

1 other study available for benzbromarone and Melanoma

ArticleYear
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cass

1997